
1. plos genet. 2012;8(11):e1002992. doi: 10.1371/journal.pgen.1002992. epub 2012 nov
1.

population genomic scan candidate signatures balancing selection guide 
antigen characterization malaria parasites.

amambua-ngwa a(1), tetteh kk, manske m, gomez-escobar n, stewart lb, deerhake me,
cheeseman ih, newbold ci, holder aa, knuepfer e, janha o, jallow m, campino s,
macinnis b, kwiatkowski dp, conway dj.

author information: 
(1)medical research council unit, fajara, banjul, gambia.

acquired immunity vertebrates maintains polymorphisms endemic pathogens,
leading identifiable signatures balancing selection. comprehensively
survey genes selection human malaria parasite plasmodium
falciparum, generated paired-end short-read sequences parasites clinical
isolates endemic gambian population, mapped 3d7 strain 
reference genome yield high-quality genome-wide coding sequence data 65
isolates. minority genes map reliably, including hypervariable
var, rifin, stevor families, 5,056 genes (90.9% genome) had
>70% sequence coverage minimum read depth 5 least 50 isolates, 
which 2,853 genes contained 3 single nucleotide polymorphisms (snps) 
analysis polymorphic site frequency spectra. overall background 
negatively skewed frequencies, expected historical population expansion
combined purifying selection, outlying minority genes signatures
indicating exceptionally intermediate frequencies identified. comparing
genes different stage-specificity, signatures common those
with peak expression merozoite stage invades erythrocytes. members of
clag, pfmc-2tm, surfin, msp3-like gene families highly represented, 
strongest signature msp3-like gene pf10_0355. analysis msp3-like 
transcripts 45 clinical 11 laboratory adapted isolates grown to
merozoite-containing schizont stages revealed surprisingly low expression of
pf10_0355. diverse clonal parasite lines protein product expressed 
a minority mature schizonts (<1% lines âˆ¼10% clone hb3), and
eight sub-clones hb3 cultured separately intermediate spectrum of
positive frequencies (0.9 7.5%), indicating phase variable expression 
polymorphic antigen. identified targets balancing selection are
now prioritized functional study.

doi: 10.1371/journal.pgen.1002992 
pmcid: pmc3486833
pmid: 23133397  [indexed medline]

conflict interest statement: authors declared competing
interests exist.

